Observe Medical ASA - Received Innovation Norway Loan Commitment of NOK 15 million

19 Dec 2025 15:30 CET

Oslo, 19 December 2025 - Observe Medical ASA (the "Company" or "Observe
Medical", OSE ticker "OBSRV") has received a loan commitment from Innovation
Norway for a loan of NOK 15 million to support the continued commercialisation
of the Company's UnoMeterT product portfolio, and commercial preparation for the
launch of Sippi®.

The availability of the loan is subject to execution of final loan documentation
and certain customary conditions precedent.

Further information regarding final terms and drawdown will be provided once the
loan agreement has been executed.

Jørgen Mann, CEO of Observe Medical, commented: "We consider the loan commitment
from Innovation Norway to be an important milestone for Observe Medical. During
2025, the Company completed equity financings raising gross proceeds of NOK 58.5
million, and in combination with the loan from Innovation Norway we are now able
increase the speed and momentum in the ongoing commercialisation of the
UnoMeterT portfolio including the rollout of the defined product pipeline.
Furthermore, it will allow us to take steps to implement our full corporate
strategy to be a partner for the Nordic innovative ecosystem within the Medtech
area"

This information is considered to constitute inside information pursuant to the
EU Market Abuse Regulation and is subject to disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act. This announcement was
published by Johan Fagerli, CFO, on 19. December 2025 at 15:30 CET

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.

More information:
Access the news on Oslo Bors NewsWeb site